Modern adjunctive pharmacotherapy of myocardial infarction

Bibliography

• PFEFFER MA, BRAUNWALD E: Ventricular remodelingafter myocardial infarction: experimental observa-tions and clinical implications. Circulation (1990) 81:1161–1172.
   PubMed Web of Science ®Google Scholar
• GOLINO P, ASHTON JH, GLAS-GREENWALT P, MCNATT J,BUJA LM, WILLERSON JT: Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Circulation (1988) 77:678–684.
   PubMedGoogle Scholar
• PATRONO C: Aspirin as an antiplatelet drug. N Engl. J. Med. (1994) 330:1287–1294.
   PubMed Web of Science ®Google Scholar
• ISIS-2 (SECOND INTERNATIONAL STUDY OF INFARCT SURVIVAL) COLLABORATIVE GROUP: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet (1988) 2:349–360.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of aspirin.
   Google Scholar
• GOLDSTEIN RE, ANDREWS M, HALL WJ, MOSS AJ FOR THE MULTICENTER MYOCARDIAL ISCHEMIA RESEARCH GROUP: Marked reduction in long-term cardiac deaths with aspirin after a coronary event. J. Am. Coll. Cardiol. (1996) 28:326–330.
   PubMedGoogle Scholar
• COUMADIN ASPIRIN REINFARCTION STUDY (CARS) INVESTIGATORS: Randomized double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet (1997) 350:389–396.
   PubMed Web of Science ®Google Scholar
• ANTIPLATELET TRIALISTS' COLLABORATION: Collabora-tive overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarc-tion, and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. (1994) 308:81–106.
   PubMed Web of Science ®Google Scholar
• PATRIGNANI P, FILABOZZI P, PATRONO C: Selectivecumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. (1982) 69:1366–1372.
   PubMed Web of Science ®Google Scholar
• CAPRIE STEERING COMMITTEE: A randomised, blinded,trial of clopidogrel versus aspirin in patients at risk for ischaemic events (CAPRIE). Lancet (1996) 348:1329–339.
   PubMed Web of Science ®Google Scholar
• •Randomised trial evaluating the efficacy of clopidogrel.
   Google Scholar
• KLEIMAN NS, OHMAN EM, CALIFF RM et al.: Profoundinhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMO 8 Pilot Study. J. Am. Coll Cardiol (1993) 22:381–389.
   Google Scholar
• OHMAN EM, KLEIMAN NS, GACIOCH G et al FOR THEIMPACT-AMI INVESTIGATORS: Combined accelerated tissue-plasminogen activator and platelet glycopro-tein Ilb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction. Circulation (1997) 95:846.
   PubMed Web of Science ®Google Scholar
• ANTMAN EM, GIUGLIANO RP, GIBSON M et al.: Abciximab facilitates the rate and extent of thrombolysis. Results of the Thrombolysis In Myocar-dial Infarction (TIMO 14 Trial. Circulation (1999) 99:2720–2732.
   Google Scholar
• ISIS-1 (FIRST INTERNATIONAL STUDY OF INFARCT SURVIVAL) COLLABORATIVE GROUP: Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet (1986) 2:57–66.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of 6-blockade.
   Google Scholar
• ROBERTS R, ROGERS WJ, MUELLER HS et al.: Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMO II-B Study. Circulation (1991) 83:422–437.
   PubMed Web of Science ®Google Scholar
• TEO KK, YUSUF S, FURBERG CD: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA (1993) 270:1589–1595.
   PubMed Web of Science ®Google Scholar
• BETA-BLOCKER HEART ATTACK TRIAL RESEARCH GROUP: A randomized trial of propranolol in patients with acute myocardial infarction. JAMA (1982) 247:1707–1714.
   PubMed Web of Science ®Google Scholar
• THE NORWEGIAN MULTICENTER STUDY GROUP: Timolol-induced reduction in mortality and reinfarc-tion in patients surviving acute myocardial infarction. N Engl. J. Med. (1981) 304:801–807.
   PubMed Web of Science ®Google Scholar
• PFEFFER MA, BRAUNWALD E, MOYE LA et al. FOR THE SAVE INVESTIGATORS: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl. J. Med. (1992) 327:669–677.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of ACE inhibition.
   Google Scholar
• KOBER L, TORP-PEDERSEN C, CARLSEN JE et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl. J. Med. (1995) 333:1670–1676.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of ACE inhibition.
   Google Scholar
• THE ACUTE INFARCTION RAMIPRIL EFFICACY (AIRE) STUDY INVESTIGATORS: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarc-tion with clinical evidence of heart failure. Lancet (1993) 342:821–828.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of ACE inhibition.
   Google Scholar
• CLELAND JGF, ERHARDT L, MURRAY G et al. ON BEHALF OF THE AIRE STUDY INVESTIGATORS: Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investiga-tors. Eur. Heart J. (1997) 18:41–51.
   Google Scholar
• HALL AS, MURRAY GD, BALL SG, ON BEHALF OF THE AIRE STUDY INVESTIGATORS: Follow-up study of patients randomly allocated ramipril or placebo for heart failure after myocardial infarction: AIRE Extension (AIREX) Study. Lancet (1997) 349:1493–1497.
   PubMed Web of Science ®Google Scholar
• ISIS-4 (FOURTH INTERNATIONAL STUDY OF INFARCT SURVIVAL) COLLABORATIVE GROUP: ISIS-4: a random-ized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet (1995) 345:669–685.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of ACE inhibition.
   Google Scholar
• GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAV-VIVENZA NELL'INFARTO MIOCARDICO: GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet (1994) 343:1115–1122.
   PubMedGoogle Scholar
• ••Randomised trial evaluating the efficacy of ACE inhibition.
   Google Scholar
• GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAV-VIVENZA NELL' INFARCTO MIOCARDICO: Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarc-tion: the GISSI-3 Trial. J. Am. Coll. Cardiol. (1996) 27:337–344.
   PubMedGoogle Scholar
• ZUANETTI G, LATINI R, MAGGIONI AP et al. FOR THE GISSI-3 INVESTIGATORS: Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 96:4239–4245.
   PubMed Web of Science ®Google Scholar
• PEKKANEN J, LINN S, HETGG G et al.: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardio-vascular disease. N Engl. J. Med. (1990) 322:1700–1707.
   PubMed Web of Science ®Google Scholar
• SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandi-navian Simvastatin Survival Study (4S). Lancet (1994) 344:1383–1389.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of simvastatin.
   Google Scholar
• THE LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC DISEASE (LIPID) STUDY GROUP: Preven-tion of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl. J. Med. (1998) 339:1349–1357.
   PubMed Web of Science ®Google Scholar
• ••Randomised trial evaluating the efficacy of pravastatin.
   Google Scholar
• SACHS FM, PFEFFER MA, MOVE LA, et al. FOR THE CHOLESTEROL AND RECURRENT EVENTS TRIAL INVESTI-GATORS: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl.J Med. (1996) 335:1001–1009.
   PubMedGoogle Scholar
• ••Randomised trial evaluating the efficacy of pravastatin.
   Google Scholar
• TEO KK, YUSUF S, COLLINS R, et al.: Effects of intrave-nous magnesium in suspected acute myocardial infarction: an overview of the randomized trials. BMJ (1991) 303:1499–1503.
   Google Scholar
• WOODS K, FLETCHER S, ROFFE C, HAIDER Y: Intrave-nous magnesium sulfate in suspected acute myocar-dial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet (1992) 339:1553–1558.
   PubMed Web of Science ®Google Scholar
• •Randomised trial evaluating the efficacy of magnesium.
   Google Scholar
• WOODS KL, FLETCHER S: Long-term outcome after intravenous magnesium sulfate in suspected acute myocardial infarction: the second Leicester Intrave-nous Magnesium Intervention Trial (LIMIT-2). Lancet (1994) 343:816–819.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN CW, RIEDER MA, SILVERSTEIN EL,GENCHEFF NE: Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation (1995) 92:2617–2621.
   PubMed Web of Science ®Google Scholar
• SULLIVAN JM, VANDER ZWAAG R, HUGHES JP et al.:Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch. Intern. Med. (1990) 150:2557–2562.
   PubMed Web of Science ®Google Scholar
• BUSH TL, BARRETT-CONNOR E, COWAN LD et al.: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 75:1102–1109.
   PubMed Web of Science ®Google Scholar
• HULLEY S, GRADY D, BUSH T eta]. FOR THE HEART ANDESTROGEN/PROGESTIN REPLACEMENT STUDY (HERS) RESEARCH GROUP: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA (1998) 280:605–613.
   Google Scholar
• WILCOX RG, HAMPTON JR, BANKS DC et al.: Trial ofearly nifedipine in acute myocardial infarction: the TRENT study. Br. Med. J (1986) 293:1204–1208.
   PubMed Web of Science ®Google Scholar
• GOLDBOURT U, BEHAR S, REICHER-REISS H, ZION M,MANDELZWEIG L, KAPLINSKY E: Early administration of nifedipine in suspected acute myocardial infarc-tion: the Secondary Prevention Reinfarction Israeli Nifedipine Trial 2 Study. Arch. Intern. Med. (1993) 153:345–353.
   PubMed Web of Science ®Google Scholar
• THE ISRAELI SPRINT STUDY GROUP. SECONDARY PREVENTION REINFARCTION ISRAELI NIFEDIPINE TRIAL (SPRINT): A randomized intervention trial of Exp. Opin. Pharmacother. (2000) 1(3) nifedipine in patients with acute myocardial infarc-tion. Eur. Heart J. (1988) 9:354–364.
   Google Scholar
• THE MULTICENTER DILTIAZEM POSTINFARCTION TRIALRESEARCH GROUP: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl. J. Med. (1988) 319:385–392 .
   PubMedGoogle Scholar
• THE DANISH STUDY GROUP ON VERAPAMIL IN MYOCARDIAL INFARCTION: Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am. J. Cardiol. (1990) 66:779–785.
   PubMed Web of Science ®Google Scholar
• RENGO F, CARBONIN P, PAHOR M, et al: A controlledtrial of verapamil in patients with acute myocardial infarction: results of the Calcium Antagonist Reinfarc-tion Italian Study (CRIS). Am. J. Cardiol (1996) 77:365–369.
   PubMedGoogle Scholar
• KOSTER RW, DUNNING AJ: Intramuscular lidocaine forprevention of lethal arrhythmias in the prehospitali-zation phase of acute myocardial infarction. N Engl. J. Med. (1985) 313:1105–1110.
   PubMedGoogle Scholar
• DARBY S, BENNETT MA, CRUICKSHANK JC et al.: Trial ofcombined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet (1972) 1:817–819.
   PubMedGoogle Scholar
• MACMAHON S, COLLIN R, PETO R, KOSTER RW, YUSUF S:Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA (1988) 260:1910–1916.
   PubMed Web of Science ®Google Scholar
• ECHT DS, LIEBSON PR, MITCHELL LB et al: Mortality andmorbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl. J. Med. (1991) 324:781–788.
   PubMed Web of Science ®Google Scholar
• THE CARDIAC ARRHYTHMIA SUPPRESSION TRIAL II INVESTIGATORS: Effect of the antiarrhythmic moricizine on survival after myocardial infarction. N Engl. J. Med. (1992) 327:227–233.
   PubMed Web of Science ®Google Scholar
• WALDO AL, CAMM AJ, DERUYTER H et al.: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet (1996) 348:7–12.
   PubMed Web of Science ®Google Scholar
• JULIAN DG, PRESCOTT RJ, JACKSON FS, SZEKELY P: Controlled trial of sotalol for one year after myocar-dial infarction. Lancet (1982) 1:1142–1147.
   PubMed Web of Science ®Google Scholar
• BURKART F, PFISTERER M, KIOWSKI W, FOLLATH F, BURCKHARDT D: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias. Basal Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol. (1990) 16:1711–1718.
   PubMed Web of Science ®Google Scholar
• JULIAN DG, CAMM AJ, FRANGIN G et al.: Randomisedtrial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocar-dial infarction: EMIAT. Lancet (1997) 349:667–674.
   PubMedGoogle Scholar
• CAIRNS JA, CONNOLLY SJ, ROBERTS R, GENT M: Randomised trial of outcome after myocardial infarc-tion in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet (1997) 349:675–682.
   PubMed Web of Science ®Google Scholar